More Weight Loss Linked With More Benefit in STEP-HFpEF More Weight Loss Linked With More Benefit in STEP-HFpEF

Prespecified analysis of the STEP-HFpEF trial of semaglutide in people with obesity and heart failure with preserved ejection fraction showed a positive link between weight-loss amounts and outcomes.Medscape Medical News
Source: Medscape Cardiology Headlines - Category: Cardiology Tags: Cardiology News Source Type: news